Valgen Medtech

Valgen Medtech Co., Ltd. is a Hangzhou, Zhejiang-based medical device company founded in 2015 that specializes in the research, development, and manufacturing of minimally invasive interventional treatment products and technologies for structural heart diseases, particularly mitral valve and tricuspid valve repair. Operating as a subsidiary of Dino... va Medical Group, the company is headquartered in Hangzhou High-Tech Zone with an additional research and development center in Shenzhen, occupying nearly 10,000 square meters of office and manufacturing space. Valgen Medtech has applied for more than 500 patents worldwide with over 150 patents granted, and achieved Chinese unicorn status in 2020. The company's flagship product, the DragonFly Transcatheter Mitral Valve Repair System, is the first Chinese-developed transfemoral transcatheter edge-to-edge repair device for treating mitral regurgitation, successfully implanted in more than 300 patients across China with a clinical success rate of 87.5 percent. Valgen Medtech offers a comprehensive range of cardiovascular intervention solutions including transcatheter mitral valve repair systems, radiation protection screens, balloon dilation catheters, septal puncture systems, and guidewires designed to improve patient outcomes in cardiovascular interventions. The company has been accredited as a national and provincial technology-oriented small and medium enterprise, operates a high and new technology research and development center, and leads projects in China's National Key R&D Program for the 14th Five-Year Plan, serving hospitals and healthcare providers with innovative diagnosis and treatment solutions for valvular heart disease.Read More